Short peptides discovery could lead to new treatments for Alzheimer’s
The memory of mice with Alzheimer's greatly improved after they were injected with two newly discovered short peptides.
List view / Grid view
The memory of mice with Alzheimer's greatly improved after they were injected with two newly discovered short peptides.
A new study has shown a new mechanism of controlling fat production in the body which could lead to new therapies to treat obesity.
A study has shown that a mutated form of the Ebola virus protects macaque models against the disease, demonstrating an opportunity for a drug target.
Chronic inflammatory processes in ageing brains lead to lymphoma cells that have entered the brain tissue being retained.
An experiment with mice has successively blocked the immune system's T cells from killing transplanted cells.
Researchers have discovered a particular protein that is required for enterovirus replication and survival, presenting a therapeutic target.
A study has found a protein which, when depleted, resulted in Alzheimer’s disease symptoms appearing in mouse and brain tissue models.
A team has used a lentiviral capsid-based bionanoparticle system to deliver CRISPR-Cas9 gene editing therapies, reducing undesired effects.
New research findings suggest that gut microbiota may regulate lupus flares in pregnant women, presenting a therapeutic target.
A new drug discovery strategy predicts the clinical actions of new compounds to promote desired clinical responses and avoid side effects.
Scientists have discovered a molecular pathway that contributes to PAH development, which may lead to a new drug target for the disease.
Researchers have discovered that B cells aid T cells in fighting cancer, which could be an area of development for immunotherapies.
A potential treatment for polycystic kidney disease has shown positive results in animal testing.
The UK Biobank, the world’s largest genetics project, will sequence 500,000 genetic samples, which will be available to researchers everywhere.
Researchers have discovered an enzyme that is pivotal in deciding whether cells survive or die in inflammatory diseases, so provides a drug target.